This cross-sectional study characterizes annual patient out-of-pocket spending on generic vs brand-name prescription drugs in the US.
Recent Posts
- Coseropositivity to Tick-Borne Pathogens in Patients Suspected to Have Lyme Disease
- Urban and Rural Hospital Closures in Georgia, 2022-2024
- Single- vs Multiple-Dose Antibiotic Prophylaxis for Total Hip Arthroplasty
- Maternal Outcomes Among Periviable Births by Cesarean Delivery
- RSV Vaccine Effectiveness Among US Older Adults, 2023-2024 Season